×
Home Features Blog Contact

2016 / © MOLEXPLORE SKIN CANCER APP

Molexplore

Molexplore is an innovative solution for the early detection of skin cancer. MATIZ dermatoscope, together with BIG DERMA's Artificial Intelligence, brings the expertise of melanoma oncologists closer to other healhcare professionals.

Molexplore offers an innovative ecosystem for face-to-face and remote diagnostics.

Features

App's features

MATIZ is the cheapests, smallest and smartest multispectral dermatoscope in the world, capable of taking photos that reveal key information, invisible to the human eye.

The artificial intelligence algorithm, trained with multiespectral images taken with the Matiz dermatoscope and preexistent databases, will show similar lesions and guide non-specialist oncologists through a highly intuitive graphical interface.

Our software allows the interconnection between specialist and non-specialist doctors. It is an interoperable system that allows integration with EMR or HIS systems and other medical software to handle image and medical records.

Melanoma is the most dangerous of all skin cancers, accounting for more than 80% of all deaths.

1 out of 3 diagnosed cancers is a skin cancer.

Melanoma can have a good prognosis if diagnosed quickly.

Team

LEO NOMDEDEU

CEO & FOUNDER

EVA SALVADOR

CHIEF SCIENTIFIC OFFICER

ENRIQUE BOLDÓ (*)

CHIEF SCIENTIFIC MEDICAL ADVISOR

GERARD PITARCH (*)

DERMATOLOGIST

CARLOS SEGARRA

DATA SCIENTIST

MIGUEL CARBONELL

BACK-END DEVELOPER

ELENA TOMÁS

MARKETING DIRECTOR

MARICARMEN ERDOZAIN

GRAPHIC & WEB DESIGNER

MIGUEL MARÍN

FRONT-END DEVELOPER

PABLO COLLADO

FRONT-END DEVELOPER

JUAN MELERO

FRONT-END DEVELOPER

AGUSTÍN DOMINGO

FRONT-END DEVELOPER

VICENTE IBÁÑEZ

ACCOUNTING MANAGER

(*) Colabora de forma desinteresada.

Testimonies

"Great Initiative! Great app! I have never found such a useful app regarding cancer skin in the whole Googleplay. 100% recommendable!."
- Zoe Falomir -

"Felicidades por esta magnífica iniciativa. Gracias por pensar en nuestra salud y hacer posible disponer gratuitamente de esta estupenda y eficaz herramienta."
- M. Angeles Mañá -

"Muy útil. A ver si se mojan y os apoyan desde la AECC (ya lo dudo) y la sanidad pública también."
- Pedro Alarcón -

News

Blog